GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,369,000 | -0.4% | 31,461 | -0.4% | 0.12% | +19.8% |
Q1 2022 | $1,375,000 | -4.2% | 31,573 | -3.0% | 0.10% | +9.8% |
Q4 2021 | $1,436,000 | +26.0% | 32,552 | +9.1% | 0.09% | +8.2% |
Q3 2021 | $1,140,000 | +1.2% | 29,839 | +5.5% | 0.08% | +26.9% |
Q2 2021 | $1,127,000 | +9.0% | 28,294 | -2.4% | 0.07% | +1.5% |
Q1 2021 | $1,034,000 | +5.1% | 28,982 | +8.3% | 0.07% | -32.7% |
Q4 2020 | $984,000 | +25.0% | 26,752 | +27.9% | 0.10% | +21.0% |
Q3 2020 | $787,000 | -6.4% | 20,915 | +1.4% | 0.08% | -16.5% |
Q2 2020 | $841,000 | +39.5% | 20,618 | +29.5% | 0.10% | +10.2% |
Q1 2020 | $603,000 | -31.6% | 15,927 | -15.0% | 0.09% | -8.3% |
Q4 2019 | $881,000 | +19.9% | 18,745 | +8.9% | 0.10% | +12.9% |
Q3 2019 | $735,000 | +8.1% | 17,215 | +1.4% | 0.08% | -1.2% |
Q2 2019 | $680,000 | +31.3% | 16,980 | +33.2% | 0.09% | +6.2% |
Q3 2017 | $518,000 | -17.8% | 12,750 | -12.8% | 0.08% | -57.1% |
Q2 2017 | $630,000 | -99.9% | 14,620 | +17.4% | 0.19% | +10.5% |
Q1 2017 | $524,892,000 | – | 12,450 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |